Skip to main content
Noclor banner

You are here

News

Dec
28
Southampton patient shares experience of biosimilar switch programme

A local patient being treated for inflammatory bowel disease (IBD) has shared his experience of switching to a biosimilar, a type of medicine developed to be highly similar and clinically equivalent to the existing biological drug used for his tre

Dec
28
Southampton patient panel supports research and improvements in care

An excellent example of patient and public involvement, the IBD patient panel in Southampton is instrumental in driving research forward.